Fracture Fusion on Fast‐Forward: Locally Administered Deferoxamine Significantly Enhances Fracture Healing in Animal Models: A Systematic Review and Meta‐Analysis
Advanced Science · 2025
DOI: 10.1002/advs.202413290 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Advanced Science, 2025. Verfasst von Daniel Müller und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-U…. Hauptthemen laut MEDLINE: Deferoxamine, Fracture Healing, Fractures, Bone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Fractures, with a yearly incidence of 1.2%, can lead to healing complications in up to 10% of cases. The angiogenic stimulant deferoxamine (DFO) is recognized for enhancing bone healing when administered into the fracture gap. This systematic review with meta‐analysis investigates the effect of local DFO application on bone healing in rat and mouse models. EMBASE, MEDLINE (PubMed), and Web of Science are systematically searched in January 2024. The study is prospectively registered in PROSPERO (CRD42024492533), and the SYRCLE tool is used to assess study quality and risk of bias. Outcome values contain the primary endpoint bone volume fraction (BV/TV) as well as the secondary endpoints bone volume, tissue volume, bone mineral density, trabecular separation, trabecular thickness, vessel formation and the mechanical properties, assessed by µCT, angiography and mechanical strength tests. Out of 21 included studies, 18 qualify for meta‐analysis, involving 539 animals. DFO‐treated groups exhibit significantly higher BV/TV values ( p < 0.0001) compared to controls, with similarly significant improvements in secondary outcomes. These findings highlight the substantial benefit of DFO in promoting bone healing, especially after radiotherapy. Rapid clinical implementation is recommended to help patients at high risk of fracture healing complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany.
- Deutsches Rheumaforschungszentrum Berlin (DRFZ), a Leibniz Institute, 10117, Berlin, Germany.
- Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, CharitéCenter for Orthopedics und Traumatology, 10117, Berlin, Germany.
- MVZ Endokrinologikum Berlin am Gendarmenmarkt, 10117, Berlin, Germany.
ORCID-Profile: Daniel Müller, Jens Klotsche, Magdalena B Kosik, Carsten Perka, Frank Buttgereit, Paula Hoff, Timo Gaber
Förderung
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Müller, D., Klotsche, J., Kosik, M. B., Perka, C., Buttgereit, F., Hoff, P., & Gaber, T. (2025). Fracture Fusion on Fast‐Forward: Locally Administered Deferoxamine Significantly Enhances Fracture Healing in Animal Models: A Systematic Review and Meta‐Analysis. Advanced Science. https://doi.org/10.1002/advs.202413290
Vancouver
Müller D, Klotsche J, Kosik MB, Perka C, Buttgereit F, Hoff P, et al. Fracture Fusion on Fast‐Forward: Locally Administered Deferoxamine Significantly Enhances Fracture Healing in Animal Models: A Systematic Review and Meta‐Analysis. Advanced Science. 2025. doi:10.1002/advs.202413290
BibTeX
@article{Mller2025,
author = {Müller, Daniel and Klotsche, Jens and Kosik, Magdalena B and Perka, Carsten and Buttgereit, Frank and Hoff, Paula and Gaber, Timo},
title = {Fracture Fusion on Fast‐Forward: Locally Administered Deferoxamine Significantly Enhances Fracture Healing in Animal Models: A Systematic Review and Meta‐Analysis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202413290}
}
EUVIMED